TY - JOUR T1 - Extravasation of Liposomal Doxorubicin Induces Irritant Reaction without Vesicant Injury JF - Anticancer Research JO - Anticancer Res SP - 1481 LP - 1483 VL - 32 IS - 4 AU - ELSA CURTIT AU - LOÏC CHAIGNEAU AU - JULIEN PAUCHOT AU - THIERRY NGUYEN AU - VIRGINIE NERICH AU - FERNANDO BAZAN AU - ANTOINE THIERY-VUILLEMIN AU - MARTIN DEMARCHI AU - XAVIER PIVOT AU - CRISTIAN VILLANUEVA Y1 - 2012/04/01 UR - http://ar.iiarjournals.org/content/32/4/1481.abstract N2 - Anthracycline extravasation is an uncommon but very serious complication. Very few data are available in the literature concerning the consequences and the management of extravasation of liposomal doxorubicin. This report describes the cases of two patients with liposomal doxorubicin extravasation who developed irritant reaction without vesicant or necrotic lesions. It is concordant with other cases described in the literature and suggests that extravasation of liposomal doxorubicin can be relatively well tolerated. The process applied to extravasations of irritant and non-vesicant agents could be used to manage extravasations of liposomal doxorubicin. ER -